Details of the Drug Formulations

General Information of Drug (ID: DM70DTN)

• Drug Name: Flibanserin Drug Info
• Synonyms: Flibanserin [USAN]; Bimt 17; Bimt-17; 1,3-Dihydro-1-(2-(4-(3-(trifluoromethyl)phenyl)-1-piperazinyl)ethyl)-2H-benzimidazol-2-one; 1-(2-(4-(3-Trifluoromethylphenyl)piperazin-1-yl)ethyl)benzimidazol(1H)-2-one; 1-(2-(4-(alpha,alpha,alpha-Trifluoro-m-tolyl)-1-piperazinyl)ethyl)-2-benzimidazolinone; 1-(2-(4-alpha,alpha,alpha-Trifluoro-m-tolyl)-1-piperazinyl)ethyl)-2-benzimidazolinone; 3-[2-[4-[4-(trifluoromethyl)phenyl]piperazin-1-yl]ethyl]-1H-benzimidazol-2-one

Indication

Disease Entry	ICD 11	Status	REF
Depression	6A70-6A7Z	Approved	[1]
Hypoactive sexual desire disorder		Approved	[1]
Mood disorder	6A60-6E23	Approved	[2]
Psychosexual disorder		Approved	[1]
Female sexual arousal dysfunction	HA01.1	Phase 3	[2]

• Cross-matching ID:
  PubChem CID: 6918248
  ChEBI ID: CHEBI:90865
  CAS Number: 167933-07-5
  TTD ID: D0S9CB
  INTEDE ID: DR0701
  ACDINA ID: D00279

Full List of Drug Formulations Containing This Drug

Flibanserin 100 mg tablet

Company	Formulation ID	FDA Description
Sprout Pharmaceuticals	F08300	Lactose monohydrate; Magnesium stearate; Ferric oxide red; Talc; Titanium dioxide; Croscarmellose sodium; Hypromellose, unspecified; Microcrystalline cellulose; Polyethylene glycol, unspecified

References

• [1] Flibanserin FDA Label
• [2] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8182).